Chemicals - Inorganic Stocks in India
Chemicals - Inorganic: Deepak Nitrite Ltd owns the largest revenue base; Fischer Medical Ventures Ltd has the fastest current growth.
The 9 Chemicals - Inorganic companies listed in India are Deepak Nitrite Ltd (₹21.7K Cr, the largest), Tanfac Industries Ltd, Archean Chemical Industries Ltd and 6 more. 5 of 9 covered companies beat NIFTY 500 on relative strength. Readings are as of 17 Sep 2026.
All 9 Chemicals - Inorganic Stocks in India (Sep 2026) — ranked by 4-Factor score
- 1Indo Borax & Chemicals Ltd₹1.6K Cr67.4/100Favorable setup · strongest on relative strength versus sector and profit growth
- 2Tanfac Industries Ltd₹7.3K Cr54.4/100Mixed-positive evidence · strongest on ROCE and relative strength versus sector
- 3J.G.Chemicals Ltd₹2.3K Cr54.4/100Mixed-positive evidence · strongest on ROCE and revenue growth
- 4Ganesh Benzoplast Ltd₹948 Cr52.0/100Mixed-positive evidence · strongest on profit growth and operating margin
- 5Deepak Nitrite Ltd₹21.7K Cr51.9/100Mixed-positive evidence · strongest on PEG and margin improvement
- 6Sree Rayalaseema Hi-Strength Hypo Ltd₹899 Cr51.4/100Mixed-positive evidence · strongest on own-history P/E and ROCE improvement
- 7POCL Enterprises Ltd₹433 Cr44.5/100Mixed-negative evidence · strongest on ROCE and sector-relative P/E
- 8Fischer Medical Ventures Ltd₹2.5K Cr44.2/100Mixed-negative evidence · strongest on profit growth and ROCE improvement
- 9Archean Chemical Industries Ltd₹5.8K Cr26.1/100Adverse evidence · strongest on PEG and operating margin
Ranked by the 4-Factor Sector Score (growth & earnings 35, capital efficiency 25, valuation 20, relative strength 20). Prices as of 11 Sep 2026. Not investment advice.
Nifty Chemicals - Inorganic Index — Constituents & Performance
All 9 listed Indian Chemicals - Inorganic companies are named here, largest first — the same constituent set people search for as the Nifty Chemicals - Inorganic index. Every figure is equal-weighted across those companies and carries its own as-of date. One large constituent cannot set the reading.
- Deepak Nitrite Ltd₹21.7K Cr
- Tanfac Industries Ltd₹7.3K Cr
- Archean Chemical Industries Ltd₹5.8K Cr
- Fischer Medical Ventures Ltd₹2.5K Cr
- J.G.Chemicals Ltd₹2.3K Cr
- Indo Borax & Chemicals Ltd₹1.6K Cr
- Ganesh Benzoplast Ltd₹948 Cr
- Sree Rayalaseema Hi-Strength Hypo Ltd₹899 Cr
- POCL Enterprises Ltd₹433 Cr
How has Chemicals - Inorganic moved against NIFTY 500?
The line below covers up to 5.2 years and opens on the 5Y view; the buttons cut it shorter. Over the most recent two of them this sector is 25% ahead of NIFTY 500. Earnings across its companies grew 8% on average over the last four reported quarters — close to flat. It has been ahead of NIFTY 500 on a rolling three-month view for 30 weeks running.
RS ↑30w · 5/8 >200d (−1) · 5/8 lead (+0) · EPS 5/8↑
Both lines start at 200 in the same week, so the distance between them is the whole story: the sector line is an equal-weighted index of 8 of its 9 companies — the 1 with too short a price record are ranked in the scorecard but cannot sit in this line. The bars underneath are trailing 12-month earnings per share, one bar per reported quarter, each member rebased to 100 at the start and the sector taking the median — so a price line pulling away from flat bars is a re-rating, not earnings. A bar turns red when that figure is lower than the quarter before. Rules are fixed and applied identically everywhere on this site: ahead by 5% or more over three months, or behind by 20% or more over a year while earnings grew 20% or more. Hover any point to read both values and the gap. This is a description of what the numbers did, not advice.
Is Chemicals - Inorganic outperforming NIFTY 500?
Chemicals - Inorganic has underperformed NIFTY 500 by 0.1% over the last 52 weeks. Over 13 weeks the gap is a lead of 13.8%. 5 of 9 covered companies currently beat NIFTY on Mansfield relative strength, so leadership inside the sector is selective. Indo Borax & Chemicals Ltd is the strongest against the sector itself at +40.6%.
Sector metric: 45.8 as of 2026-08-22 · NARROWING · rising.
The central tension: the companies with the most scale are not necessarily the companies creating the most change.
Start with scale. Then earnings trajectory. Then business quality. Only after those three agree should price leadership carry much weight.
Bottom line
Chemicals - Inorganic has underperformed NIFTY 500 by 0.1% over 52 weeks and 13.8% over 13 weeks. 5 of 9 covered companies beat NIFTY on Mansfield relative strength, while 2 of 9 beat the sector itself. Deepak Nitrite Ltd leads with revenue of ₹8,575 crore, based on 9 of 9 comparable companies through Jun 2026.
4-Factor Sector Score
An additive sector-relative research score. The four displayed point contributions always equal the total: Growth & earnings (35), Capital efficiency (25), Valuation (20), and Relative strength (20). Missing or stale evidence is absorbed inside the affected factor, never applied as a hidden adjustment.
How this score is built, and what the marks mean
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Indo Borax & Chemicals LtdINDOBORAX | 67.4/100Favorable setup87% evidence | LEADER | 26.9/35 Revenue 28.9% · PAT 47.4% · OPM change 5 pp 95% evidence | 17.9/25 ROCE 15.4% · OPM 28% 95% evidence | 6.2/20 P/E 31.8× · PEG — 50% evidence | 16.4/20 RS sector 40.6% · RS bench 60.1% · 1Y 102%12 of 12 weeks ahead 100% evidence |
| Exact sum: 26.9 + 17.9 + 6.2 + 16.4 = 67.4 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence. | ||||||
| 2Tanfac Industries LtdTANFACIND | 54.4/100Mixed-positive evidence82% evidence | LEADER | 10.8/35 Revenue 13.2% · PAT -29.2% · OPM change -1 pp 95% evidence | 18.5/25 ROCE 23.9% · OPM 15% 76% evidence | 6.2/20 P/E 108× · PEG — 50% evidence | 18.9/20 RS sector 30.2% · RS bench 48.9% · 1Y 45%12 of 12 weeks ahead 100% evidence |
| Exact sum: 10.8 + 18.5 + 6.2 + 18.9 = 54.4 · Decision use: Price leads the evidence: RS versus the benchmark is 48.9%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 3J.G.Chemicals LtdJGCHEM | 54.4/100Mixed-positive evidence74% evidence | BREAKING OUT | 21.3/35 Revenue 24% · PAT 16.4% · OPM change 2 pp 95% evidence | 13.0/25 ROCE 18.1% · OPM 11% 95% evidence | 10.0/20 P/E 30.9× · PEG — 15% evidence | 10.1/20 RS sector -5.5% · RS bench 43.6% · 1Y 25.9%10 of 10 weeks ahead 70% evidence |
| Exact sum: 21.3 + 13 + 10 + 10.1 = 54.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 4Ganesh Benzoplast LtdGANESHBE | 52.0/100Mixed-positive evidence74% evidence | BREAKING OUT | 15.6/35 Revenue 13.1% · PAT 87.2% · OPM change -7 pp 95% evidence | 15.0/25 ROCE 14.6% · OPM 23% 95% evidence | 10.8/20 P/E 14.5× · PEG — 15% evidence | 10.6/20 RS sector -4.4% · RS bench 43.5% · 1Y 37.8%9 of 11 weeks ahead 70% evidence |
| Exact sum: 15.6 + 15 + 10.8 + 10.6 = 52 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 5Deepak Nitrite LtdDEEPAKNTR | 51.9/100Mixed-positive evidence100% evidence | BASING | 21.4/35 Revenue 7.1% · PAT 29.4% · OPM change 11 pp 100% evidence | 10.1/25 ROCE 11.4% · OPM 21% 100% evidence | 16.4/20 P/E 27.3× · PEG 0.61 100% evidence | 4.0/20 RS sector -15.7% · RS bench -2.9% · 1Y -9.2%4 of 12 weeks ahead 100% evidence |
| Exact sum: 21.4 + 10.1 + 16.4 + 4 = 51.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 6Sree Rayalaseema Hi-Strength Hypo LtdSRHHYPOLTD | 51.4/100Mixed-positive evidence81% evidence | TURNING | 16.4/35 Revenue 7.6% · PAT 1.1% · OPM change -1 pp 95% evidence | 12.4/25 ROCE 14% · OPM 14% 95% evidence | 14.0/20 P/E 9.1× · PEG — 50% evidence | 8.6/20 RS sector -13.1% · RS bench 5.9% · 1Y -15.8%2 of 10 weeks ahead 70% evidence |
| Exact sum: 16.4 + 12.4 + 14 + 8.6 = 51.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 7POCL Enterprises LtdPOEL | 44.5/100Mixed-negative evidence69% evidence | 7.8/35 Revenue 4.6% · PAT -2% · OPM change -3 pp 95% evidence | 17.3/25 ROCE 26.4% · OPM 2.5% 76% evidence | 11.1/20 P/E 11.9× · PEG — 15% evidence | 8.3/20 RS sector -3.3% · RS bench -24.6% · 1Y -41.4%2 of 12 weeks ahead 70% evidence | |
| Exact sum: 7.8 + 17.3 + 11.1 + 8.3 = 44.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 8Fischer Medical Ventures LtdFISCHER | 44.2/100Mixed-negative evidence83% evidence | FADING | 26.1/35 Revenue 100% · PAT 100% · OPM change -3.3 pp 100% evidence | 4.2/25 ROCE 11.4% · OPM 13.7% 100% evidence | 8.9/20 P/E 102× · PEG — 15% evidence | 5.0/20 RS sector -35% · RS bench -26.1% · 1Y -67.6%2 of 12 weeks ahead 100% evidence |
| Exact sum: 26.1 + 4.2 + 8.9 + 5 = 44.2 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -35% and the one-year return is -67.6%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 9Archean Chemical Industries LtdACI | 26.1/100Adverse evidence100% evidence | ASLEEP | 4.3/35 Revenue -0.4% · PAT -39.9% · OPM change -6 pp 100% evidence | 7.6/25 ROCE 7.4% · OPM 21% 100% evidence | 12.7/20 P/E 60× · PEG 0.83 100% evidence | 1.5/20 RS sector -27.2% · RS bench -15.9% · 1Y -31.6%0 of 12 weeks ahead 100% evidence |
| Exact sum: 4.3 + 7.6 + 12.7 + 1.5 = 26.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
Market action
Indo Borax & Chemicals Ltd has the strongest one-year price move in Chemicals - Inorganic at +102%. It also leads on Mansfield relative strength against NIFTY at +60.1%. 5 of 9 covered companies are above zero on that measure. Every line covers 313 weekly closes through 2026-09-11.
Every company, the sector's own index and NIFTY 500 all start level on the left edge of the window, so only the distance between the lines counts — the highest line has risen the most since then, and the chart at the top of this page is drawn the same way. It opens on one year; the buttons beside it stretch that to three or five.
How far ahead of or behind NIFTY 500 each company has been running, measured against its own recent average of that comparison, so the flat line at zero IS NIFTY 500: above it the company is beating the market, below it the market is beating the company. It opens on one year.
The same measure taken against Chemicals - Inorganic itself instead of the whole market, so the flat line at zero is the sector: above it the company is beating its own peers, which is the sharper test of the two. It opens on one year.
Chemicals - Inorganic — the story behind the numbers
This is the written read behind the Chemicals - Inorganic figures above — what is actually happening in the sector, in words, with the evidence each claim rests on. It is dated 25 Jul 2026. 5 themes are live here, 1 of them rated high severity.
The Chemicals - Inorganic sector analysis this week focuses on FISCHER, where data indicates a sharp divergence between top-line growth and bottom-line stability. Consolidated revenue from operations grew nearly 99% YoY to ₹97.73 Cr, yet profitability collapsed as operating margins fell to 1.03% from 21.34% in Q3 FY26.
How old this read is: This read comes from our Chemicals - Inorganic sector brief dated 25 Jul 2026 — 54 days old. The numbers above it are newer than the words here.
What is live in this sector right now
| Live theme | Severity | Evidence on file |
|---|---|---|
| Operating margin collapsed from 21.34% in Q3 FY26 to 1.03% in Q4 FY26, indicating severe cost pressures.Named for FISCHER | high | “Operating profit (PBDIT excluding other income) plummeted to just ₹1.01 crores in Q4 FY26—the lowest in at least seven quarters—yielding an operating margin of merely 1.03%” |
| Interest costs surged indicating working capital financing requirements for inventory and logistics.Named for FISCHER | medium | “Interest costs surged to ₹3.61 crores in Q4 FY26, the highest quarterly level recorded, up from just ₹0.64 crores in Q3 FY26” |
| SpinCare FDA filing outcome expected Q4 FY26; Phase 2 MDR/MDD audit due October 2025.Named for FISCHER | medium | Preparing SpinCare FDA filing; outcome expected Q4 FY26 |
| International subsidiaries in Singapore, Malaysia, and Indonesia expose company to currency fluctuations.Named for FISCHER | low | No further detail is on file for this theme. |
| Stock has tumbled 56.45% over the past year with multiple lower circuit hits.Named for FISCHER | low | No further detail is on file for this theme. |
Sources: our Chemicals - Inorganic sector brief, 25 Jul 2026 · company earnings-call transcripts.
Revenue Scale & Growth Durability
Deepak Nitrite Ltd has the highest Revenue among the 9 Chemicals - Inorganic companies compared here, at ₹8,575 crore. POCL Enterprises Ltd is next at ₹1,525 crore. Fischer Medical Ventures Ltd has the highest Revenue growth at the 100% top of the scoring scale, so level and change sit with different companies.
What the numbers say: Deepak Nitrite Ltd is the scale leader at ₹8,575 crore, 462.2% ahead of POCL Enterprises Ltd. Fischer Medical Ventures Ltd's growth is stored at the ≥100% scoring cap; the uncapped TTM change is 195.8% from a ₹367 crore base, with 15 reported observations in the 20-quarter window. Treat the growth leader as an acceleration candidate, not as equally proven scale.
Investor read: Deepak Nitrite Ltd is the scale benchmark; Fischer Medical Ventures Ltd is the acceleration watch. Promote the challenger only if growth persists and converts into margin and returns.
This conclusion weakens if: Deepak Nitrite Ltd's growth falls below Fischer Medical Ventures Ltd's for two consecutive comparable reports while operating margin also compresses.
On every company-comparison chart on this page: solid lines show level, dotted lines show change when “Both” is selected, and a missing report breaks the line rather than being invented.
All-company data · latest reported quarter
In every all-company table on this page, each figure is the company’s latest single reported quarter. The rankings above them use trailing-twelve-month or current-market values, so a company can legitimately show a different number in each.
| Company | Revenue | Revenue growth | Reported |
|---|---|---|---|
| Deepak Nitrite Ltd DEEPAKNTR | ₹2.6K Cr | 36% | Jun 2026 |
| POCL Enterprises Ltd POEL | ₹466 Cr | 25% | Jun 2026 |
| Archean Chemical Industries Ltd ACI | ₹327 Cr | 12% | Jun 2026 |
| J.G.Chemicals Ltd JGCHEM⚠ unverified | ₹316 Cr | 45% | Jun 2026 |
| Sree Rayalaseema Hi-Strength Hypo Ltd SRHHYPOLTD⚠ unverified | ₹211 Cr | 17% | Jun 2026 |
| Tanfac Industries Ltd TANFACIND | ₹187 Cr | 6.3% | Jun 2026 |
| Ganesh Benzoplast Ltd GANESHBE⚠ unverified | ₹118 Cr | 23% | Jun 2026 |
| Fischer Medical Ventures Ltd FISCHER | ₹82 Cr | 249% | Jun 2026 |
| Indo Borax & Chemicals Ltd INDOBORAX⚠ unverified | ₹70 Cr | 30% | Jun 2026 |
Full 20-quarter history · every available company
Revenue · reported quarter history
Deepak Nitrite Ltd · DEEPAKNTR
Fischer Medical Ventures Ltd · FISCHER
Ganesh Benzoplast Ltd · GANESHBE⚠ unverified
Indo Borax & Chemicals Ltd · INDOBORAX⚠ unverified
J.G.Chemicals Ltd · JGCHEM⚠ unverified
POCL Enterprises Ltd · POEL
Sree Rayalaseema Hi-Strength Hypo Ltd · SRHHYPOLTD⚠ unverified
Tanfac Industries Ltd · TANFACIND
Revenue growth · reported quarter history
Archean Chemical Industries Ltd · ACI
Deepak Nitrite Ltd · DEEPAKNTR
Fischer Medical Ventures Ltd · FISCHER
Ganesh Benzoplast Ltd · GANESHBE⚠ unverified
Indo Borax & Chemicals Ltd · INDOBORAX⚠ unverified
J.G.Chemicals Ltd · JGCHEM⚠ unverified
POCL Enterprises Ltd · POEL
Sree Rayalaseema Hi-Strength Hypo Ltd · SRHHYPOLTD⚠ unverified
Tanfac Industries Ltd · TANFACIND
Operating Economics & Margin Trend
Indo Borax & Chemicals Ltd has the highest OPM among the 9 Chemicals - Inorganic companies compared here, at 28%. Ganesh Benzoplast Ltd is next at 23%. Deepak Nitrite Ltd has the highest Margin change at +11 percentage points, so level and change sit with different companies. 9 of 9 companies report a comparable reading, the latest through Jun 2026.
What the numbers say: Indo Borax & Chemicals Ltd leads opm at 28%; Deepak Nitrite Ltd leads margin change at +11 percentage points.
Investor read: Indo Borax & Chemicals Ltd sets the level benchmark; use the change leader as an inflection watch only after another comparable report confirms it.
This conclusion weakens if: The next two comparable reports reverse the current margin change signal.
All-company data · latest reported quarter
| Company | OPM | Margin change | Reported |
|---|---|---|---|
| Indo Borax & Chemicals Ltd INDOBORAX⚠ unverified | 28% | +5.0 pp | Jun 2026 |
| Ganesh Benzoplast Ltd GANESHBE⚠ unverified | 23% | −7.0 pp | Jun 2026 |
| Deepak Nitrite Ltd DEEPAKNTR | 21% | +11.0 pp | Jun 2026 |
| Archean Chemical Industries Ltd ACI | 21% | −6.0 pp | Jun 2026 |
| Tanfac Industries Ltd TANFACIND | 15% | −1.0 pp | Jun 2026 |
| Sree Rayalaseema Hi-Strength Hypo Ltd SRHHYPOLTD⚠ unverified | 14% | −1.0 pp | Jun 2026 |
| Fischer Medical Ventures Ltd FISCHER | 14% | −3.3 pp | Jun 2026 |
| J.G.Chemicals Ltd JGCHEM⚠ unverified | 11% | +2.0 pp | Jun 2026 |
| POCL Enterprises Ltd POEL | 2.5% | −3.0 pp | Jun 2026 |
Full 20-quarter history · every available company
OPM · reported quarter history
Archean Chemical Industries Ltd · ACI
Deepak Nitrite Ltd · DEEPAKNTR
Fischer Medical Ventures Ltd · FISCHER
Ganesh Benzoplast Ltd · GANESHBE⚠ unverified
Indo Borax & Chemicals Ltd · INDOBORAX⚠ unverified
J.G.Chemicals Ltd · JGCHEM⚠ unverified
POCL Enterprises Ltd · POEL
Sree Rayalaseema Hi-Strength Hypo Ltd · SRHHYPOLTD⚠ unverified
Tanfac Industries Ltd · TANFACIND
Margin change · reported quarter history
Archean Chemical Industries Ltd · ACI
Deepak Nitrite Ltd · DEEPAKNTR
Fischer Medical Ventures Ltd · FISCHER
Ganesh Benzoplast Ltd · GANESHBE⚠ unverified
Indo Borax & Chemicals Ltd · INDOBORAX⚠ unverified
J.G.Chemicals Ltd · JGCHEM⚠ unverified
POCL Enterprises Ltd · POEL
Sree Rayalaseema Hi-Strength Hypo Ltd · SRHHYPOLTD⚠ unverified
Tanfac Industries Ltd · TANFACIND
Profit Scale & Acceleration
Deepak Nitrite Ltd has the highest Net profit among the 9 Chemicals - Inorganic companies compared here, at ₹784 crore. Archean Chemical Industries Ltd is next at ₹95 crore. Fischer Medical Ventures Ltd has the highest Profit growth at the 100% top of the scoring scale, so level and change sit with different companies.
What the numbers say: Deepak Nitrite Ltd leads with ₹784 crore of TTM profit, 725.3% above Archean Chemical Industries Ltd. Fischer Medical Ventures Ltd shows ≥100% on the scoring scale (296.8% uncapped) growth from a ₹24 crore profit base. Compare the size of the base and persistence before ranking acceleration above profit scale.
Investor read: Deepak Nitrite Ltd sets the level benchmark; use the change leader as an inflection watch only after another comparable report confirms it.
This conclusion weakens if: The next two comparable reports reverse the current profit growth signal.
All-company data · latest reported quarter
| Company | Net profit | Profit growth | Reported |
|---|---|---|---|
| Deepak Nitrite Ltd DEEPAKNTR | ₹345 Cr | 208% | Jun 2026 |
| Archean Chemical Industries Ltd ACI | ₹30 Cr | -25% | Jun 2026 |
| J.G.Chemicals Ltd JGCHEM⚠ unverified | ₹26 Cr | 63% | Jun 2026 |
| Sree Rayalaseema Hi-Strength Hypo Ltd SRHHYPOLTD⚠ unverified | ₹25 Cr | 14% | Jun 2026 |
| Ganesh Benzoplast Ltd GANESHBE⚠ unverified | ₹18 Cr | 0.0% | Jun 2026 |
| Tanfac Industries Ltd TANFACIND | ₹17 Cr | -11% | Jun 2026 |
| Indo Borax & Chemicals Ltd INDOBORAX⚠ unverified | ₹16 Cr | 60% | Jun 2026 |
| POCL Enterprises Ltd POEL | ₹6 Cr | -46% | Jun 2026 |
| Fischer Medical Ventures Ltd FISCHER | ₹4 Cr | -22% | Jun 2026 |
Full 20-quarter history · every available company
Net profit · reported quarter history
Archean Chemical Industries Ltd · ACI
Deepak Nitrite Ltd · DEEPAKNTR
Fischer Medical Ventures Ltd · FISCHER
Ganesh Benzoplast Ltd · GANESHBE⚠ unverified
Indo Borax & Chemicals Ltd · INDOBORAX⚠ unverified
J.G.Chemicals Ltd · JGCHEM⚠ unverified
POCL Enterprises Ltd · POEL
Sree Rayalaseema Hi-Strength Hypo Ltd · SRHHYPOLTD⚠ unverified
Tanfac Industries Ltd · TANFACIND
Profit growth · reported quarter history
Archean Chemical Industries Ltd · ACI
Deepak Nitrite Ltd · DEEPAKNTR
Fischer Medical Ventures Ltd · FISCHER
Ganesh Benzoplast Ltd · GANESHBE⚠ unverified
Indo Borax & Chemicals Ltd · INDOBORAX⚠ unverified
J.G.Chemicals Ltd · JGCHEM⚠ unverified
POCL Enterprises Ltd · POEL
Sree Rayalaseema Hi-Strength Hypo Ltd · SRHHYPOLTD⚠ unverified
Tanfac Industries Ltd · TANFACIND
Return On Capital Employed
POCL Enterprises Ltd has the highest ROCE among the 9 Chemicals - Inorganic companies compared here, at 26.4%. Tanfac Industries Ltd is next at 23.9%. Fischer Medical Ventures Ltd has the highest ROCE change at +9.2 percentage points, so level and change sit with different companies. 9 of 9 companies report a comparable reading, the latest through Jun 2026.
What the numbers say: POCL Enterprises Ltd leads ROCE at 26.4%, 2.5 percentage points above Tanfac Industries Ltd. Fischer Medical Ventures Ltd has the strongest latest improvement at +9.2 percentage points. Read the leader beside the density of its reported history: a sparse high return is a candidate; a repeated high return is evidence of durability.
Investor read: POCL Enterprises Ltd sets the level benchmark; use the change leader as an inflection watch only after another comparable report confirms it.
This conclusion weakens if: The next two comparable reports reverse the current roce change signal.
All-company data · latest reported quarter
| Company | ROCE | ROCE change | Reported |
|---|---|---|---|
| J.G.Chemicals Ltd JGCHEM⚠ unverified | 14% | −2.9 pp | Jun 2026 |
| Indo Borax & Chemicals Ltd INDOBORAX⚠ unverified | 12% | −2.3 pp | Jun 2026 |
| Deepak Nitrite Ltd DEEPAKNTR | 10% | −2.9 pp | Jun 2026 |
| Ganesh Benzoplast Ltd GANESHBE⚠ unverified | 9.9% | −3.9 pp | Jun 2026 |
| Fischer Medical Ventures Ltd FISCHER | 9.7% | +9.2 pp | Jun 2026 |
| Sree Rayalaseema Hi-Strength Hypo Ltd SRHHYPOLTD⚠ unverified | 7.7% | −0.9 pp | Jun 2026 |
| Archean Chemical Industries Ltd ACI | 6.6% | −4.1 pp | Jun 2026 |
Full 20-quarter history · every available company
ROCE · reported quarter history
Archean Chemical Industries Ltd · ACI
Deepak Nitrite Ltd · DEEPAKNTR
Fischer Medical Ventures Ltd · FISCHER
Ganesh Benzoplast Ltd · GANESHBE⚠ unverified
Indo Borax & Chemicals Ltd · INDOBORAX⚠ unverified
J.G.Chemicals Ltd · JGCHEM⚠ unverified
Sree Rayalaseema Hi-Strength Hypo Ltd · SRHHYPOLTD⚠ unverified
ROCE change · reported quarter history
Archean Chemical Industries Ltd · ACI
Deepak Nitrite Ltd · DEEPAKNTR
Fischer Medical Ventures Ltd · FISCHER
Ganesh Benzoplast Ltd · GANESHBE⚠ unverified
Indo Borax & Chemicals Ltd · INDOBORAX⚠ unverified
J.G.Chemicals Ltd · JGCHEM⚠ unverified
Sree Rayalaseema Hi-Strength Hypo Ltd · SRHHYPOLTD⚠ unverified
Valuation Against Growth & Quality
Deepak Nitrite Ltd has the lowest PEG among the 9 Chemicals - Inorganic companies compared here, at 0.61×. Archean Chemical Industries Ltd is next at 0.83×. Sree Rayalaseema Hi-Strength Hypo Ltd has the lowest P/E at 9.12×, so level and change sit with different companies. 2 of 9 companies report a comparable reading, the latest through Jun 2026.
What the numbers say: Deepak Nitrite Ltd has the lowest comparable PEG at 0.61×, 26.5% below Archean Chemical Industries Ltd. Only 2 of 9 companies have earnings and growth steady enough for the ratio to mean anything, so no broad “cheapest stock” conclusion is defensible unless the current multiple, own-history position and growth durability agree.
Investor read: Treat valuation as permission to investigate, never as a standalone reason to buy.
This conclusion weakens if: The next two comparable reports reverse the current p/e signal.
All-company data · latest reported quarter
| Company | PEG | P/E | Reported |
|---|---|---|---|
| Archean Chemical Industries Ltd ACI | 0.8 | 62.6 | Jun 2026 |
| Deepak Nitrite Ltd DEEPAKNTR | 0.6 | 39.5 | Jun 2026 |
| Tanfac Industries Ltd TANFACIND | — | 68.7 | Jun 2026 |
| Fischer Medical Ventures Ltd FISCHER | — | 78.9 | Jun 2026 |
| J.G.Chemicals Ltd JGCHEM⚠ unverified | — | 24.8 | Jun 2026 |
| Indo Borax & Chemicals Ltd INDOBORAX⚠ unverified | — | 28.5 | Jun 2026 |
| Ganesh Benzoplast Ltd GANESHBE⚠ unverified | — | 11.2 | Jun 2026 |
| Sree Rayalaseema Hi-Strength Hypo Ltd SRHHYPOLTD⚠ unverified | — | 8.4 | Jun 2026 |
| POCL Enterprises Ltd POEL | — | 12.7 | Jun 2026 |
Full 20-quarter history · every available company
PEG · reported quarter history
Archean Chemical Industries Ltd · ACI
Deepak Nitrite Ltd · DEEPAKNTR
P/E · reported quarter history
Archean Chemical Industries Ltd · ACI
Deepak Nitrite Ltd · DEEPAKNTR
Fischer Medical Ventures Ltd · FISCHER
Ganesh Benzoplast Ltd · GANESHBE⚠ unverified
Indo Borax & Chemicals Ltd · INDOBORAX⚠ unverified
J.G.Chemicals Ltd · JGCHEM⚠ unverified
POCL Enterprises Ltd · POEL
Sree Rayalaseema Hi-Strength Hypo Ltd · SRHHYPOLTD⚠ unverified
Tanfac Industries Ltd · TANFACIND
What can make this comparison misleading?
This Chemicals - Inorganic comparison names 6 specific ways its own evidence can mislead, all listed below. All 9 companies here report on comparable dates, so no rank carries a stale marker. 4 draw at least one figure from a second feed with too little overlap to cross-check. A high growth rate can still be a low-base artefact.
Keep these limits visible
- A high growth rate can be a low-base artefact. The page keeps level and change separate for that reason.
- A high ROCE can be temporary or flattered by a small capital base. Read it beside margin, cash conversion and reinvestment.
- The 4-Factor Sector Score ranks research priority, not portfolio action. Management quality, catalysts and risks need equally fresh evidence before capital is deployed.
- An “all companies” line chart preserves completeness, but rank changes should be checked against reporting dates before drawing a conclusion.
- 4 companies draw at least one figure from a second data feed with too little overlapping history to cross-check against the primary source; they are marked unverified wherever those figures appear.
- Thin comparisons: Valuation have fewer than three usable current readings.
How was this comparison built?
This comparison is built from the reported filings of 9 Chemicals - Inorganic companies, normalized to a common ₹ scale and a shared quarter axis of up to 20 quarters each. Fundamentals run through Jun 2026 and market data through 2026-09-11. A second data feed fills gaps only after identity and scale reconciliation, and missing observations are never interpolated.
How a second data feed is admitted, and what happens when it disagrees
A second feed is read only after its reported income is matched against the primary source on at least three overlapping periods. Where the two agree the figures fill silently. Where there is too little shared history to compare, the figures are still drawn — they are the only evidence there is — and marked ⚠ unverified everywhere they appear. Where the two are known to disagree, nothing from the second feed is drawn and the affected company is named under the chart it is missing from.
Chemicals - Inorganic company comparison FAQs
These 24 answers restate the Chemicals - Inorganic comparison above in question form. Every one is computed from the same 9 companies and the same reported filings as the rankings and charts, current through Jun 2026. Price and relative-strength answers run through 2026-09-11. Nothing here is estimated, and none of it is a recommendation.
Is the Chemicals - Inorganic sector outperforming NIFTY 500?
Chemicals - Inorganic has underperformed NIFTY 500 by 0.1% over 52 weeks and 13.8% over 13 weeks. 5 of 9 covered companies beat NIFTY on Mansfield relative strength, while 2 of 9 beat the sector itself.
Which Chemicals - Inorganic company is largest by revenue?
Deepak Nitrite Ltd leads with revenue of ₹8,575 crore, based on 9 of 9 comparable companies through Jun 2026.
Which Chemicals - Inorganic company is growing fastest?
Fischer Medical Ventures Ltd has the fastest current revenue growth at 100%, across 9 of 9 comparable companies.
Which Chemicals - Inorganic company has the strongest 4-Factor Sector Score?
Indo Borax & Chemicals Ltd ranks first at 67.4/100 with 87% evidence confidence. The score prioritizes research; it is not a buy recommendation.
Which Chemicals - Inorganic company has the lowest comparable PEG?
Deepak Nitrite Ltd has the lowest comparable PEG at 0.61, among 2 of 9 companies whose earnings and growth are steady enough for the ratio to mean anything.
How much history does this Chemicals - Inorganic comparison include?
The page compares up to 20 reported quarters per company for fundamentals, returns and valuation, ending Jun 2026. Missing observations remain blank rather than being estimated.
How is the 4-Factor Sector Score calculated?
The four visible contributions add directly: growth and earnings up to 35 points, capital efficiency up to 25, valuation up to 20, and relative strength up to 20. Missing or stale evidence moves only the affected contribution toward neutral.
Is there a Nifty Chemicals - Inorganic index?
NSE India maintains Nifty indices for several broad sector categories — Nifty Bank, Nifty IT, Nifty Pharma and others — but not for every sub-sector grouping on this site. Whether or not an official Nifty index covers Chemicals - Inorganic, this page builds its own equal-weight basket of 9 listed Chemicals - Inorganic companies — one company, one vote, regardless of market value — so no single large company dominates the reading. Figures are as of Jun 2026.
Which are the best Chemicals - Inorganic stocks in India?
Ranked by this page's four-factor score, Indo Borax & Chemicals Ltd places first among 9 listed Chemicals - Inorganic companies, followed by Tanfac Industries Ltd. That is a ranking of published data — earnings, quality, valuation and market behaviour as of Jun 2026 — and not a recommendation; Sector Alpha is not registered with SEBI as an investment adviser.
How many Chemicals - Inorganic stocks are listed in India?
This comparison covers 9 listed Chemicals - Inorganic companies in India, each above the size floor the site applies, with 20 quarters of reported figures per company where the filings exist. The full ranked list is on this page, as of Jun 2026.
Which Chemicals - Inorganic company is the biggest?
Deepak Nitrite Ltd is the largest, with trailing-twelve-month revenue of ₹8,575 crore, ahead of POCL Enterprises Ltd at ₹1,525 crore. That covers 9 of 9 companies with comparable reporting through Jun 2026.
Which Chemicals - Inorganic company has the best profit margins?
Indo Borax & Chemicals Ltd has the highest operating margin at 28%, from 9 of 9 comparable companies. Deepak Nitrite Ltd shows the biggest recent improvement, at +11 percentage points. A high margin matters most when it is holding or rising, not when it is peaking.
Which Chemicals - Inorganic company makes the most profit?
Deepak Nitrite Ltd earns the most, at ₹784 crore of trailing-twelve-month net profit, from 9 of 9 comparable companies. Fischer Medical Ventures Ltd has the fastest profit growth at the ≥100% scoring cap, though growth off a small or recovering profit base overstates how much has actually changed.
Which Chemicals - Inorganic company earns the highest return on capital?
POCL Enterprises Ltd leads on return on capital employed at 26.4%, across 9 of 9 companies. Read it beside the length of its reported history: a high return that repeats for years is evidence of a durable business, while a single high reading can be a small capital base or one good year.
Which Chemicals - Inorganic stock is the cheapest?
On PEG — where a LOWER number is cheaper — Deepak Nitrite Ltd screens cheapest at 0.61×. Only 2 of 9 companies have earnings and growth steady enough for the ratio to mean anything, so this is not a sector-wide "cheapest stock" verdict. Cheap on a multiple is a reason to investigate, never a reason to buy on its own.
Is the Chemicals - Inorganic sector beating the market?
Chemicals - Inorganic has underperformed NIFTY 500 by 0.1% over the last 52 weeks and 13.8% over 13 weeks, measured on an equal-weight index of its current members. Inside the sector, 5 of 9 covered companies are beating the market on their own. Sector strength does not transfer evenly to every stock in it.
Which Chemicals - Inorganic stock has the strongest price momentum?
Indo Borax & Chemicals Ltd has the strongest relative strength against NIFTY 500. Relative strength answers last, after growth, quality and valuation: price can move well before the fundamentals confirm it, and sometimes without them confirming at all.
Which Chemicals - Inorganic company scores highest for research priority?
Indo Borax & Chemicals Ltd scores 67.4 out of 100 with 87% evidence confidence, from 26.9 points on growth and earnings, 17.9 on capital efficiency, 6.2 on valuation and 16.4 on relative strength. This ranks what deserves work next. It is not a buy recommendation, and management quality, catalysts and risk still need separate research.
How many Chemicals - Inorganic companies does this comparison cover, and over what period?
It compares 9 listed companies over up to 20 reported quarters of fundamentals, ending Jun 2026, plus weekly price and relative-strength history. Membership is the full sector list — nothing is dropped for having thin data.
What is the total market cap of the Chemicals - Inorganic sector?
The 9 Chemicals - Inorganic companies on this page carry ₹43,436 crore of combined market value. Deepak Nitrite Ltd is the largest at ₹21,656 crore, about 50% of the sector's total on its own. Market value moves with price, so this reading is dated 2026-09-17.
What is the Chemicals - Inorganic sector's P/E ratio?
The median price-to-earnings ratio across the 9 Chemicals - Inorganic companies on this page is 30.9×, measured on the 9 that report a comparable figure. A sector-level history for this multiple is not held here, so this is a cross-section of today, not a comparison with the sector’s own past. Figures are as of 2026-09-17.
How is the Chemicals - Inorganic sector performing?
5 of the 9 covered Chemicals - Inorganic companies are beating NIFTY 500 on Mansfield relative strength. The sector itself is 0.1% behind NIFTY 500 over 52 weeks on an equal-weight index of its current members. Readings are as of 2026-09-17.
Why are some values on this page blank?
A blank means that company did not report a comparable figure for that period, so nothing is shown. Missing observations are never interpolated, carried forward, or replaced with a similar-looking accounting line, and a company with missing evidence has its research score pulled toward neutral rather than being scored as bad.
Is this investment advice?
No. Every figure here is a deterministic calculation from reported company filings and market data, published for research. It contains no recommendation to buy or sell any security, does not account for your circumstances, and is not a substitute for advice from a licensed adviser.
Not SEBI Registered !! Not Investment advice !!